Bridging Studies News

The development of a Bridging Strategy is a key component of any successful development program aimed to deliver new medicines to the largest Pharmaceutical markets. Since the implementation of ICH E5 in 1998 on the acceptability of foreign clinical data into regional approvals, many different approaches have been taken by researchers to allow the fastest registration in all markets.